Shaw Rietkerk Sells 25,000 Shares of AdaptHealth Corp. (NASDAQ:AHCO) Stock

AdaptHealth Corp. (NASDAQ:AHCO) COO Shaw Rietkerk sold 25,000 shares of AdaptHealth stock in a transaction on Friday, September 20th. The shares were sold at an average price of $11.24, for a total transaction of $281,000.00. Following the transaction, the chief operating officer now owns 212,611 shares in the company, valued at approximately $2,389,747.64. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $10.19 on Thursday. The firm has a 50-day moving average of $10.75 and a two-hundred day moving average of $10.44. The company has a debt-to-equity ratio of 1.38, a current ratio of 1.15 and a quick ratio of 0.94. The stock has a market cap of $1.37 billion, a P/E ratio of -1.93, a PEG ratio of 1.73 and a beta of 1.10. AdaptHealth Corp. has a 1-year low of $6.37 and a 1-year high of $11.90.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.19 by ($0.06). AdaptHealth had a positive return on equity of 9.58% and a negative net margin of 21.20%. The business had revenue of $805.98 million for the quarter, compared to analysts’ expectations of $802.62 million. During the same quarter in the prior year, the firm earned $0.16 earnings per share. AdaptHealth’s revenue for the quarter was up 1.6% compared to the same quarter last year. On average, research analysts expect that AdaptHealth Corp. will post 0.87 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $13.00 target price on shares of AdaptHealth in a research report on Monday, August 12th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $10.70.

Institutional Investors Weigh In On AdaptHealth

A number of institutional investors have recently modified their holdings of AHCO. Mackenzie Financial Corp lifted its holdings in AdaptHealth by 48.6% during the 2nd quarter. Mackenzie Financial Corp now owns 34,489 shares of the company’s stock worth $345,000 after buying an additional 11,280 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in AdaptHealth by 8.1% during the second quarter. The Manufacturers Life Insurance Company now owns 39,440 shares of the company’s stock worth $394,000 after purchasing an additional 2,959 shares during the last quarter. MBB Public Markets I LLC acquired a new position in AdaptHealth in the second quarter worth $142,000. Dark Forest Capital Management LP bought a new stake in AdaptHealth during the second quarter valued at $384,000. Finally, Caxton Associates LP acquired a new stake in shares of AdaptHealth during the second quarter worth $383,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.